3. The UK’s Innovation Network
Introducing the Knowledge Transfer Network
• The KTN is the UK’s innovation network. It brings together businesses,
entrepreneurs, academics and funders to develop new products, processes and
services
• We help business to grow the economy and improve people’s lives by
capturing maximum value from innovative ideas, scientific research and
creativity
What we do Industry
Funders
Research
6. KTN Priority Areas
Health
Clinical Needs
Stratified
Medicine
Anti-Microbial
Resistance
Regenerative
Medicine
Independent Living
Emerging Medical
Technologies
High Value
ManufacturingOver- -arching
Digital Health,
including Data
7. Technologies that
Diagnose, treat and manage disease and injury
Improve the quality of life
improve assisted living
detect and I.D. infectious agents
Aid stratified medicine innovation
Predict behavior and control manufacture of complex formulated
products
Key Priority Areas
Emerging medical technologies
8. Innovate UK with BBSRC EPSRC MRC
Investing to support development and application of non animal technologies
Aim: Not purely to replace animal models but to improve medical
development
Business led collaborations with 50 to 60 % funding
Key Priority Area
Developing Non Animal Technologies
9. Biological
Tissue engineeering, Imaging, cell line technology
-omics genomics proteomics, epigenomics
In vitro markers - stratified medicine
Use of non mammalian organisms
Manufacturing
High throughput technologies/ combinatorial chemistry
Microfluidics/ microstructured surfaces
Automation and control
Computational
Math modelling – in silico modelling
Data mining and analysis
Key Priority Area
Developing Non Animal Technologies
10. Future healthcare will require complicated and innovative data manipulation,
storage and sharing
Market growth from $3.8b worldwide in 2013 to $9.1b by 2018
Challenges
Data Integration
In Silico modelling & algortihms to predict toxicity, predicting process and
product understanding
Visualisation tools – facilitating exploratory analysis
Open Innovation and pre-competitive approaches
Key Priority Area
Bioinformatics Integrated –omics challenge
11. S Academic excellence, Databases, Gov support
W Bioinformaticians, poor understanding in bioscience, in house
software solutions, lack of commercialisation skills
O Traction in UK, High demand and immature market, academic
collaboration. Biotech is growing and depending on –omics,
Education now being tailored to suit needs
T Poor IP protection, US more mature, open source nature
Key Priority Area
Bioinformatics Integrated –omics challenge
12. Drivers for Health today and tomorrow
• Demographics – increasing demand
• Increase in Long Term Conditions – 1 in 3 people
with a Long Term Condition
• Unsustainable health & care systems/models –
treating ill health
• Health inequalities
• Infection and antimicrobial resistance
• Personalisation agenda and self care
• Patient expectations
• Technology revolution
• Increasing healthcare spend
13. Technologies/Enablers:
• Additive Layer Manufacture
• Biochemistry
• Health Economics
• High Value Manufacturing
• ICT (including data)
• Imaging
• Materials
• Modelling and Simulation
• Nanotechnology
• Photonics and Sensors
• Surface coatings/ modifications
• Etc.
Medical Technologies
Prevention, diagnostics and therapy:
• Assisted/Independent Living
• Cardiovascular
• Dental
• Diabetes
• Diagnostics
• Drug Delivery
• Minimally Invasive Surgery
• Musculoskeletal
• Trauma
• Urology
• Wound Management
• Etc.
14. Its complex ……But people are available to help
I need funding……There are schemes at both regional and UK
level
I need knowledge……The UK is rich in Centres of Excellence
I need a supply chain……Design, contract manufacturing and
professional services are out there
If all else fails…..
Summary
For SMEs